Transcript Hemispheric Drug Strategy CICAD/OAS

Hemispheric Drug Strategy CICAD/OAS
October, 2010
Hemispheric Drug Strategy
• The High Level Group for updating Hemispheric Drug Strategy
completed the process, after carrying out 4 consultative
meetings that resulted in the development of 5 drafts and
finally in the document presented at the 47th Ordinary Session
of CICAD. Likewise, the General Assembly of the Organization of
American States at its fortieth regular session in Lima, Peru,
June 2010 resolved to endorse the strategy.
• Hemispheric Anti-Drug Strategy leads to the Hemispheric Drug
Strategy, which contains a semantic change that means a
profound conceptual change as can be seen in the highlights:
Hemispheric Drug Strategy
• Emphasis on the need to respect human rights in the implementation of
Public Policies on Drugs.
• Recognize that poverty and marginalization are elements of vulnerability
for the use and trafficking of drugs, and also recognized the need to
develop social inclusion policies as a way to mitigate these vulnerabilities.
• Includes the concept of gender in the formulation of public policies on this
issue.
• Highlights the importance of institutional strengthening for the
development of Public Policies on Drugs.
• Debate highlights the importance of national and hemispheric levels, to
promote the participation of the scientific community, policy makers and
the community.
• Expressly recognizes that drug dependency is a chronic, relapsing disease
with biological, psychological and social and as such should be treated in
the field of Public Health.
• Highlights the necessity and importance of Public Policies on Drugs, in all
its aspects, be based on scientific evidence.
Plan of action of the Hemispheric Drug Strategy
• In the 47 Regular Session of CICAD approved
the delegation of Mexico as General
Coordinator of the process of developing the
Action Plan.
• Also adopted the "Proposed methodology
and course of action for the construction of
the Plan of Action on Drug Strategy in the
Hemisphere."
Plan of action of the Hemispheric Drug Strategy
To facilitate dialogue in the HLG there will be a general coordinator and 5 subcoordinators by thematic area. Each of the sub-coordinators will work as facilitators of
the dialogue: integrating the proposals and actions received by the Member States
and identifying the agreeing and disagreeing elements. The general coordinator will
be responsible for the development of the proposals consolidated in different
thematic areas and will promote consensus among the Member States.
Thematic Areas
Coordinator
General coordination
Mexico
Institutional Building:
Surinam
Demand Reduction:
United States
Supply Reduction:
Colombia
Control Measures:
Argentina
International Cooperation:
Venezuela
Building the initial proposal
• Update of the Draft presented before the HLG
of the Strategy, based on the Hemispheric
Drug Strategy.
• Preparation of an analysis based on the
application of a questionnaire, in which the
Member States express what they need and
can offer in terms of the actions required for
the implementation of the Hemispheric Drug
Strategy.
Building the initial proposal
Focal Points
• For the development of the Action Plan that
allows the implementation of the Hemispheric
Drug Strategy, a High Level Group (HLG) is
created with the participation of all Member
States of CICAD and 23 focal points have been
designated to represent them in the process
and as far as possible to act as a liaison among
the stakeholders in the Member States.
Dynamic of the Negotiation
• Virtual Forum: A secure virtual space was created to facilitate
this communication. The Group published all the different
proposals, support materials and promoted the interaction
among the focal points of each Member State, in this virtual
space.
• From the initial proposal, it is expected that the Member
States will present observations and recommendations, which
will be differentiated and separated by thematic area. The
coordinators will analyze the different proposals to
differentiate and reconcile them. In order to do this, they will
interact with those who have made proposals, through the
available virtual tools, particularly through the secure virtual
forum which will be created.
Dynamic of the Negotiation
• Through the platform we will receiving
proposals until October 31st.
• To finalize the electronic consultations a
reviewed version of the Action Plan proposal
will be developed and distributed to the
Member States in preparation for an
upcoming in person session.
Plan of action of the Hemispheric Drug Strategy
• The HLG will meet in person from
November 8th to the 11th, in
Washington D.C.
How to access the platform?
Select “English” to read the instructions
ENGLISH
Action Plan’s Virtual Community
for the implementation of the
Hemispheric Drug Strategy
http://www.cicad.oas.org/community
The system will automatically send
the password to the e-mail address
which you had registered.
After registering the first time
you can access the System anytime.
You must register first in order
to access the System.
Register
Enter a username
Type a password with at least 8 characters
and, must include a symbol or special
character (!@#$%^&*.,)
Argentina
******************
******************
[email protected]
Type your e-mail address
[email protected]
Select the time zone
Mark the box, if you agree with the terms and
conditions.

Select “Join now” to save your information.
Register
• If your data has
been
successfully
registered, the
system will
show a
welcome
message.
• Select CICAD
from the
toolbar.
Register
•
•
For security
reasons, all the
users must be
verified before
granted access.
The System will
show a window
to request the
access.
Just left the
message box in
blank and, select
“Request
Membership”.
Register
• After the
username has
been verified,
you will receive
an e-mail
confirmation.
Login
Type your username
Enter your password
Select “Sign In” to access the
system.
Plan de Acción
Estrategia Hemisférica sobre Drogas
Bienvenidos al Foro Virtual para la Construcción del Plan de Acción Hemisférico sobre Drogas.
Aspiramos a que esta plataforma se constituya en una herramienta central para el intercambio de
información con miras a avanzar en el proceso de negociación, a fin de integrar la propuesta de
Plan de Acción encomendado por los Comisionados de la CICAD.
Te invitamos a que lo utilices como el medio primordial de comunicación y lo adecues a tus
necesidades, ya que su diseño base busca ser una plataforma amigable y flexible que te brinde los
elementos necesarios para conducir consultas y formular propuestas.
--- O --Welcome to the Virtual Forum for the Construction of the Hemispheric Action Plan on Drugs. We
hope that this platform becomes a major tool for exchanging information in order to advance the
negotiation process aimed at integrating the Action Plan requested by the Commissioners of the
CICAD.
We invite you to use it as the primary means of communication and that you adapt it to suit your
needs, since its basic design seeks to be a friendly and flexible platform that gives you the
necessary information to conduct consultations and make proposals.
Terms and Conditions
By using this web site, User agrees to the Conditions and Disclaimer set out below:
a)
The General Secretariat of the Organization of American States (“GS/OAS”) maintains this web site for
information purposes only. Users may download, copy and reprint information from the site for noncommercial purposes so long as the GS/OAS is cited as the source of the originating material, however,
they may not resell, redistribute, or create derivative works absent the express written permission of
GS/OAS.
b)
Unless otherwise indicated, the materials published on this web site, including opinions expressed
therein, are the responsibility of the individual authors/compilers and not those of the Organization of
American States (“OAS”), GS/OAS, and the OAS Member States or its member countries.
d)
e)
f)
This site contains links to web sites not under GS/OAS control. The GS/OAS provides those links as a
convenience for users of its site and is not responsible for their contents. The presence of a link does
not imply endorsement or approval of its contents by the OAS, GS/OAS, its personnel, or the OAS
Member States.
All information on this web site is “as is”. The OAS makes no warranty, express or implied, as to the
accuracy or completeness of any of the material on this web site and GS/OAS, its personnel, and OAS
are is not liable, jointly, severally, or in any other way, for any expense or damages of any kind incurred
as a consequence of its use, including expense or damages arising from communication failure and/or
computer malfunctions associated with use of the site. Moreover, GS/OAS, its personnel, and OAS are
not liable for any actions taken in reliance on or otherwise based upon the information on this web site.
c)
GS/OAS at its sole discretion, may, without notice and for any reason whatsoever:
a)
b)
c)
remove any and all content of the Forums, regardless of its origin, and
deny any user access to this web site.
Use of this web site will result in the storage of certain information about User on
GS/OAS’ server, including, but not limited to, internet protocol (IP), navigation
through the site, items purchased, credit card information submitted by User,
software used, and time spent, user’s address, and user’s name if provided. The
primary purpose of this information is to help GS/OAS make the site more
responsive to Users and particularly those who are repeat Users. GS/OAS, its
personnel, and OAS assume no responsibility for the security of that information.
Users who elect the option of registering on the site will have a “cookie” created on
their hard drive to facilitate user management of subscriptions and the user’s online
profile.
d)
Nothing in these Conditions and Disclaimer constitutes a waiver of the privileges
and immunities of OAS, GS/OAS, or its personnel.
As a condition of use of this web site, the User agrees to indemnify GS/OAS, OAS, and OAS organs from
and against any and all actions, law suits, damages and expenses, including court costs and legal fees,
arising out of User’s use of this web site and the information herein contained.
If User is dissatisfied with the information on this web site, User’s sole and exclusive remedy is to cease
using it.
not to defame, abuse, harass, stalk, threaten or otherwise violate the legal rights of
others;
not to publish, distribute or disseminate any defamatory, infringing, obscene,
indecent or unlawful material or information;
not to upload or attach files that contain viruses, corrupted files, software that may
damage the operation of another’s hardware, and material protected by intellectual
property laws without first obtaining the permission of the intellectual property
rights holder;
not delete any author attributions, legal notices, or labels in any file uploaded;
not falsify the origin or source of software in uploaded material;
not advertise or sell any goods or services or conduct or forward surveys, contests or
chain letters, or download any file that User knows or reasonably should know
cannot be legally distributed by such method.
User acknowledges that all Forums and discussion groups are public and not private communications.
Users of the online forums pages contained on this site may not engage in any illegal or defamatory
practices and are bound by the agreements described therein. The OAS reserves the right to remove at
any time and without notice material sent to such forums. In using or otherwise participating in those
Forums (including chat rooms and discussion groups), User agrees:
http://www.oas.org/en/terms_conditions.asp
Thank you.
Organization of American States
Inter-American Drug Abuse Control Commission
1889 F Street, N.W.
Washington, DC 20006
Phone. 202.458.3179 Fax. 202.458.3658